Literature DB >> 8165094

Difficulties in assigning human immunodeficiency virus-1 infection and seroreversion status in a cohort of HIV-exposed in children using serologic criteria established by the Centers for Disease Control and Prevention.

B J Simpson1, W A Andiman.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8165094

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  11 in total

1.  Constraints and prospects in the management of pediatric HIV/AIDS.

Authors:  Edamisan O Temiye; Adebola O Akinsulie; Chinyere V Ezeaka; Ifedayo M O Adetifa; Edna O Iroha; Adenike O Grange
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

Review 2.  Pediatric human immunodeficiency virus infection.

Authors:  J B Domachowske
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

3.  Pediatric human immunodeficiency virus screening in an African district hospital.

Authors:  A J De Baets; B S Edidi; M J Kasali; G Beelaert; W Schrooten; A Litzroth; P Kolsteren; D Denolf; K Fransen
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

4.  Assessing the Variability of Cell-Associated HIV DNA Quantification through a Multicenter Collaborative Study.

Authors:  Yann Le Duff; Kathleen Gärtner; Eloise J Busby; Annalisa Dalzini; Sivapragashini Danaviah; José Luis Jiménez Fuentes; Carlo Giaquinto; Jim F Huggett; Matthew Hurley; Anne-Geneviève Marcellin; María Ángeles Muñoz-Fernández; Denise M O'Sullivan; Deborah Persaud; Laura Powell; Peter Rigsby; Paolo Rossi; Anita de Rossi; Lilly Siems; Theresa Smit; Sarah A Watters; Neil Almond; Eleni Nastouli
Journal:  Microbiol Spectr       Date:  2022-06-06

5.  Three cases of HIV-1 seroreversion.

Authors:  V Tarján; E Ujhelyi; J Szabó; R Kellner; G Krall; A Gyuris; I Mihály; G Füst
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

6.  Absolute CD4+ T-lymphocyte count as a surrogate marker of pediatric human immunodeficiency virus disease progression.

Authors:  Elijah Paintsil; Musie Ghebremichael; Sostena Romano; Warren A Andiman
Journal:  Pediatr Infect Dis J       Date:  2008-07       Impact factor: 2.129

7.  Utility of rapid antibody tests to exclude HIV-1 infection among infants and children aged <18 months in a low-resource setting.

Authors:  Ann M Buchanan; Behzad Nadjm; Ben Amos; George Mtove; David Sifuna; Coleen K Cunningham; John A Crump; Hugh Reyburn
Journal:  J Clin Virol       Date:  2012-08-24       Impact factor: 3.168

8.  Has highly active antiretroviral therapy increased the time to seroreversion in HIV exposed but uninfected children?

Authors:  Mavel Gutierrez; David A Ludwig; Safia S Khan; Aida A Chaparro; Delia M Rivera; Amanda M Cotter; Gwendolyn B Scott
Journal:  Clin Infect Dis       Date:  2012-07-31       Impact factor: 9.079

9.  Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials.

Authors:  Laura Powell; Adit Dhummakupt; Lilly Siems; Dolly Singh; Yann Le Duff; Priyanka Uprety; Cheryl Jennings; Joseph Szewczyk; Ya Chen; Eleni Nastouli; Deborah Persaud
Journal:  J Clin Virol       Date:  2021-04-14       Impact factor: 14.481

10.  The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.

Authors:  Lorna Dunning; Jordan A Francke; Divya Mallampati; Rachel L MacLean; Martina Penazzato; Taige Hou; Landon Myer; Elaine J Abrams; Rochelle P Walensky; Valériane Leroy; Kenneth A Freedberg; Andrea Ciaranello
Journal:  PLoS Med       Date:  2017-11-21       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.